Ribavirin-resistant variants of foot-and-mouth disease virus: The effect of restricted quasispecies diversity on viral virulence

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4008-4020

  Zeng, Jianxiong ^a   Wang, Haiwei ^a   Xie, Xiaochun ^a   Li, Chen ^a   Zhou, Guohui ^a   Yang, Decheng ^a   Yu, Li ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; GENETIC VARIABILITY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE GENETICS; SPECIES DIVERSITY; VIRUS ATTENUATION; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VARIATION; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RIBAVIRIN; RNA REPLICASE; VIRAL PROTEINS; VIRULENCE;

EID: 84896904367     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03594-13     Document Type: Article

References (51)

1. Mason PW, Grubman MJ, Baxt B. 2003. Molecular basis of pathogenesis of FMDV. Virus Res. 91:9-32. http://dx.doi.org/10.1016/S0168-1702(02) 00257-5.
2. Domingo E, Escarmis C, Baranowski E, Ruiz-Jarabo CM, Carrillo E, Nunez JI, Sobrino F. 2003. Evolution of foot-and-mouth disease virus. Virus Res. 91:47-63. http://dx.doi.org/10.1016/S0168-1702(02)00259-9.
3. Melo EC, Saraiva V, Astudillo V. 2002. Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication. Rev. Sci. Tech. 21:429-436. http://bvs1.panaftosa.org.br/local/file/textoc/CorreaReview2002.pdf.
4. Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V. 2001. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32:1-30. http://dx.doi.org/10.1051/vetres:2001106.
5. Knowles NJ, Samuel AR. 2003. Molecular epidemiology of foot-andmouth disease virus. Virus Res. 91:65-80. http://dx.doi.org/10.1016/S0168-1702(02)00260-5.
6. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL. 2005. Comparative genomics of foot-and-mouth disease virus. J. Virol. 79:6487-6504. http://dx.doi.org/10.1128/JVI.79.10.6487-6504.2005.
7. Grubman MJ, Baxt B. 1982. Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology 116:19-30. http://dx.doi.org/10.1016/0042-6822(82)90399-3.
8. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493. http://dx.doi.org/10.1128/CMR.17.2.465-493.2004.
9. Schaaper RM. 1998. Antimutator mutants in bacteriophage T4 and Escherichia coli. Genetics 148:1579-1585.
10. Airaksinen A, Pariente N, Menendez-Arias L, Domingo E. 2003. Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311:339-349. http://dx.doi.org/10.1016/S0042-6822(03)00144-2.
11. Chen R, Quinones-Mateu ME, Mansky LM. 2004. Drug resistance, virus fitness and HIV-1 mutagenesis. Curr. Pharm. Des. 10:4065-4070. http://dx.doi.org/10.2174/1381612043382404.
12. Ruiz-Jarabo CM, Ly C, Domingo E, Torre JC. 2003. Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37-47. http://dx.doi.org/10.1016/S0042-6822(02) 00046-6.
13. Crotty S, Cameron CE, Andino R. 2001. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U. S. A. 98:6895-6900. http://dx.doi.org/10.1073/pnas.111085598.
14. Goris N, De Palma A, Toussaint JF, Musch I, Neyts J, De Clercq K. 2007. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus. Antiviral Res. 73:161-168. http://dx.doi.org/10.1016/j.antiviral.2006.09.007.
15. Pariente N, Sierra S, Airaksinen A. 2005. Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Res. 107:183-193. http://dx.doi.org/10.1016/j.virusres.2004.11.008.
16. Loeb LA, Mullins JI. 2000. Lethal mutagenesis of HIV by mutagenic ribonucleoside analogs. AIDS Res. Hum. Retroviruses 16:1-3. http://dx.doi.org/10.1089/088922200309539.
17. Graci JD, Gnadig NF, Galarraga JE, Castro C, Vignuzzi M, Cameron CE. 2012. Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis. J. Virol. 86:2869-2873. http://dx.doi.org/10.1128/JVI.05712-11.
18. Crotty S, Cameron C, Andino R. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. (Berl.) 80:86-95. http://dx.doi.org/10.1007/s00109-001-0308-0.
19. Anderson JP, Daifuku R, Loeb LA. 2004. Viral error catastrophe by mutagenic nucleosides. Annu. Rev. Microbiol. 58:183-205. http://dx.doi.org/10.1146/annurev.micro.58.030603.123649.
20. Martin V, Grande-Perez A, Domingo E. 2008. No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus. Virology 378:185-192. http://dx.doi.org/10.1016/j.virol.2008.05.016.
21. Sierra S, Davila M, Lowenstein PR, Domingo E. 2000. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J. Virol. 74:8316-8323. http://dx.doi.org/10.1128/JVI.74.18.8316-8323.2000.
22. Chung DH, Sun Y, Parker WB, Arterburn JB, Bartolucci A, Jonsson CB. 2007. Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus. J. Virol. 81:11722-11729. http://dx.doi.org/10.1128/JVI.00874-07.
23. Coffey LL, Beeharry Y, Borderia AV, Blanc H, Vignuzzi M. 2011. Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc. Natl. Acad. Sci. U. S. A. 108:16038-16043. http://dx.doi.org/10.1073/pnas.1111650108.
24. Levi LI, Gnadig NF, Beaucourt S, McPherson MJ, Baron B, Arnold JJ, Vignuzzi M. 2010. Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds. PLoS Pathog. 6:e1001163. http://dx.doi.org/10.1371/journal.ppat.1001163.
25. Sierra M, Airaksinen A, Gonzalez-Lopez C, Agudo R, Arias A, Domingo E. 2007. Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe. J. Virol. 81:2012-2024. http://dx.doi.org/10.1128/JVI.01606-06.
26. Pfeiffer JK, Kirkegaard K. 2003. A single mutation in poliovirus RNAdependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc. Natl. Acad. Sci. U. S. A. 100:7289-7294. http://dx.doi.org/10.1073/pnas.1232294100.
27. Vignuzzi M, Wendt E, Andino R. 2008. Engineering attenuated virus vaccines by controlling replication fidelity. Nat. Med. 14:154-161. http://dx.doi.org/10.1038/nm1726.
28. Weeks SA, Lee CA, Zhao Y, Smidansky ED, August A, Arnold JJ, Cameron CE. 2012. A polymerase mechanism-based strategy for viral attenuation and vaccine development. J. Biol. Chem. 287:31618-31622. http://dx.doi.org/10.1074/jbc. C112.401471.
29. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344-348. http://dx.doi.org/10.1038/nature04388.
30. Arias A, Arnold JJ, Sierra M, Smidansky ED, Domingo E, Cameron CE. 2008. Determinants of RNA-dependent RNA polymerase (in)fidelity revealed by kinetic analysis of the polymerase encoded by a foot-and-mouth disease virus mutant with reduced sensitivity to ribavirin. J. Virol. 82: 12346-12355. http://dx.doi.org/10.1128/JVI.01297-08.
31. Zeng J, Wang H, Xie X, Yang D, Zhou G, Yu L. 2013. An increased replication fidelity mutant of foot-and-mouth disease virus retains fitness in vitro and virulence in vivo. Antiviral Res. 100:1-7. http://dx.doi.org/10.1016/j.antiviral.2013.07.008.
32. Wang H, Zhao L, Li W, Zhou G, Yu L. 2011. Identification of a conformational epitope on the VP1 G-H loop of type Asia1 foot-andmouth disease virus defined by a protective monoclonal antibody. Vet. Microbiol. 148:189-199. http://dx.doi.org/10.1016/j.vetmic.2010.09.013.
33. Beaucourt S, Borderia AV, Coffey LL, Gnadig NF, Sanz-Ramos M, Beeharry Y, Vignuzzi M. 2011. Isolation of fidelity variants of RNA viruses and characterization of virus mutation frequency. J. Vis. Exp. 52: 2953. http://dx.doi.org/10.3791/2953.
34. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
35. Shaw AE, Reid SM, Ebert K, Hutchings GH, Ferris NP, King DP. 2007. Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. J. Virol. Methods 143:81-85. http://dx.doi.org/10.1016/j.jviromet.2007.02.009.
36. Goris N, Vandenbussche F, Herr C, Villers J, Stede YV, Clercq KD. 2009. Validation of two real-time RT-PCR methods for foot-and-mouth disease diagnosis: RNA-extraction, matrix effect, uncertainty of measurement and precision. J. Virol. Methods 160:157-162. http://dx.doi.org/10.1016/j.jviromet.2009.05.005.
37. Gutierrez-Rivas M, Pulido MR, Baranowski E, Sobrino F, Saiz M. 2008. Tolerance to mutations in the foot-and-mouth disease virus integrinbinding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. J. Gen. Virol. 89:2531-2539. http://dx.doi.org/10.1099/vir.0.2008/003194-0.
38. Baranowski E, Molina N, Nunez JI, Sobrino F, Saiz M. 2003. Recovery of infectious foot-and-mouth disease virus from suckling mice after direct inoculation with in vitro-transcribed RNA. J. Virol. 77:11290-11295. http://dx.doi.org/10.1128/JVI.77.20.11290-11295.2003.
39. Domingo E, Escarmis C, Sevilla N, Moya A, Elena SF, Quer J, Novella IS, Holland JJ. 1996. Basic concepts in RNA virus evolution. FASEB J. 10:859-864.
40. Lauring AS, Agudo R. 2010. Quasispecies theory and the behavior of RNAviruses. PLoS Pathog. 6:e1001005. http://dx.doi.org/10.1371/journal.ppat.1001005.
41. Wilke CO. 2005. Quasispecies theory in the context of population genetics. BMC Evol. Biol. 5:44. http://dx.doi.org/10.1186/1471-2148-5-44.
42. Eigen M. 1993. Viral quasispecies. Sci. Am. 269:42-49.
43. Domingo E, Martin V, Perales C, Grande-Perez A, Garcia-Arriaza J, Arias A. 2006. Viruses as quasispecies: biological implications. Curr. Top. Microbiol. Immunol. 299:51-82. http://bilder.buecher.de/zusatz/14/145 77/14577772_lese_1.pdf.
44. Garcia-Nunez S, Konig G, Berinstein A, Carrillo E. 2010. Differences in the virulence of two strains of foot-and-mouth disease virus serotype A with the same spatiotemporal distribution. Virus Res. 147:149-152. http://dx.doi.org/10.1016/j.virusres.2009.10.013.
45. Rodriguez-Pulido M, Sobrino F, Saiz M. 2011. Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection. Antiviral Res. 92:500-504. http://dx.doi.org/10.1016/j.antiviral.2011.10.005.
46. Pfeiffer JK, Kirkegaard K. 2005. Increased fidelity reduces poliovirus fitness and virulence under selected pressure in mice. PLoS Pathog. 1:e11. http://dx.doi.org/10.1371/journal.ppat.0010011.
47. Hobdey SE, Kempf BJ, Steil BP, Barton DJ, Peersen OB. 2010. Poliovirus polymerase residue 5 plays a critical role in elongation complex stability. J. Virol. 84:8072-8084. http://dx.doi.org/10.1128/JVI.02147-09.
48. Campagnola G, Weygandt M, Scoggin K, Peersen O. 2008. Crystal structure of coxsackievirus B3 3Dpol highlights the functional importance of residue 5 in picornavirus polymerases. J. Virol. 82:9458-9464. http://dx.doi.org/10.1128/JVI.00647-08.
49. Agudo R, Ferrer-Orta C, Arias A, de la Higuera I, Perales C, Perez-Luque R, Verdaguer N, Domingo E. 2010. A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape. PLoS Pathog. 6:e1001072. http://dx.doi.org/10.1371/journal.ppat.1001072.
50. Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE. 2005. Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J. Biol. Chem. 280:25706-25716. http://dx.doi.org/10.1074/jbc. M503444200.
51. Harki DA, Graci JD, Korneeva VS, Ghosh BSK, Hong Z, Cameron CE, Peterson BR. 2002. Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-β-D-ribofuranosyl-3-nitropyrrole. Biochemistry 41:9026-9033. http://dx.doi.org/10.1021/bi026120w.